Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02893228Phase 4Completed
Phase 4, randomised, double-blind trial (2 arms), sponsored by Tallaght University Hospital. Primary endpoint: Rate of diaphragmatic paresis at 4 hours. Started Oct 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02893228.